Xspray Pharma AB's total assets for Q4 2024 were kr796.34M, an increase of 19.27% from the previous quarter. DE:6XP total liabilities were kr173.25M for the fiscal quarter, a 111.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.